Alzheimer's disease brain‐derived extracellular vesicles reveal altered synapse‐related proteome and induce cognitive impairment in mice

• Published in: Alzheimer's & dementia Vol. 19; no. 12; pp. 5418 - 5436
• Main Authors: Bodart‐Santos, Victor, Pinheiro, Lisandra S., da Silva‐Junior, Almir J., Froza, Rudimar L., Ahrens, Rosemary, Gonçalves, Rafaella A., Andrade, Mayara M., Chen, Yan, Alcantara, Carolina de Lima, Grinberg, Lea T., Leite, Renata E. P., Ferreira, Sergio T., Fraser, Paul E., De Felice, Fernanda G.
• Format: Journal Article
• Language: English
• Published: United States 01.12.2023
• Subjects: Alzheimer's disease; brain‐derived EVs; extracellular vesicles; proteomics; tauopathies; tauopathies; brain-derived EVs; extracellular vesicles; proteomics; Alzheimer's disease
• ISSN: 1552-5260; 1552-5279; 1552-5279
• DOI: 10.1002/alz.13134

INTRODUCTION Extracellular vesicles (EVs) have been implicated in the spread of neuropathology in Alzheimer's disease (AD), but their involvement in behavioral outcomes linked to AD remains to be determined. METHODS EVs isolated from post mortem brain tissue from control, AD, or frontotemporal dementia (FTD) donors, as well as from APP/PS1 mice, were injected into the hippocampi of wild‐type (WT) or a humanized Tau mouse model (hTau/mTauKO). Memory tests were carried out. Differentially expressed proteins in EVs were assessed by proteomics. RESULTS Both AD‐EVs and APP/PS1‐EVs trigger memory impairment in WT mice. We further demonstrate that AD‐EVs and FTD‐EVs carry Tau protein, present altered protein composition associated with synapse regulation and transmission, and trigger memory impairment in hTau/mTauKO mice. DISCUSSION Results demonstrate that AD‐EVs and FTD‐EVs have negative impacts on memory in mice and suggest that, in addition to spreading pathology, EVs may contribute to memory impairment in AD and FTD. Highlights Aβ was detected in EVs from post mortem AD brain tissue and APP/PS1 mice. Tau was enriched in EVs from post mortem AD, PSP and FTD brain tissue. AD‐derived EVs and APP/PS1‐EVs induce cognitive impairment in wild‐type (WT) mice. AD‐ and FTD‐derived EVs induce cognitive impairment in humanized Tau mice. Proteomics findings associate EVs with synapse dysregulation in tauopathies.